Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients.
about
Transfusion transmission of HCV, a long but successful road map to safetyManaging Occupational Risks for Hepatitis C Transmission in the Health Care SettingHigh levels of subgenomic HCV plasma RNA in immunosilent infectionsTesting Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence RatesSequential bottlenecks drive viral evolution in early acute hepatitis C virus infection.Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users.Epidemiology of hepatitis C virus infection in highly endemic HBV areas in China.Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study.Awareness and performance of blood transfusion standards in operating rooms of Shiraz hospitals in 2012.Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug usersDistribution of Dengue Virus Types 1 and 4 in Blood Components from Infected Blood Donors from Puerto RicoResponse to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort.Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection.Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccineHigh rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.Host genetic basis for hepatitis C virus clearance: a role for blood collection centersTreatment of acute HCV infection.Haemoglobin-based oxygen carriers: indications and future applications.Is the 25-year hepatitis C marathon coming to an end to declare victory?Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China.Diagnosis of acute hepatitis C virus infection and estimated incidence in low- and high-risk English populations.Dynamics of viremia in early hepatitis C virus infection.Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors.Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.Cost-effective analysis of different algorithms for the diagnosis of hepatitis C virus infection.Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis.Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis.Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics.Hepatitis C virus knowledge improves hepatitis C virus screening practices among primary care physicians.The New Direct Antiviral Agents and Hepatitis C in Thoracic Transplantation: Impact on Donors and Recipients.
P2860
Q26865471-288368C6-3AEC-4E73-84BE-946C9D723FE4Q27477626-9395CC26-62D2-4F57-B312-F5EE7A422D61Q27481224-8647E972-BFDE-481B-A9DF-662E6E139BD5Q27485369-8E1B106D-2D31-4BEF-819A-C6BD1529074EQ30407004-CFC82102-812A-4C93-A959-4A769AB51162Q33824723-47C69F90-1CC6-4E38-B984-D1F94031AE59Q34571364-265DEFF8-7BBA-454B-B2E9-0DAD9985AC7EQ35249648-CB3AAFC2-29D4-4EFC-9442-F2C920321AA6Q35763372-094D9FDC-BCB2-42BC-B29A-BA70A6266AB3Q35864200-2C818F12-DCD0-40C3-957B-2CECD016B404Q35922064-7566FE07-9297-44D4-A737-E3EA52DF68D5Q36200292-B2A6CC8A-8807-4298-9941-A6EF34AE1F0AQ36523107-F1045AFA-D4ED-4583-B61B-224D53D339FDQ36717008-173B8505-DB62-49FB-BE84-107A38DEE58FQ37288631-CC19F9D9-361E-4621-BA5C-AA73F8A1C1A0Q37781667-C0AF54EC-95A3-4D30-B0D3-D0CD3D7313D3Q37855530-77AE1C13-1558-4F02-AC3D-7DBAE6A79511Q38351787-93CCA886-1AE9-407A-A874-988DC9F97486Q38556915-8FD71ADB-FB91-4013-B254-9AD062E419B2Q40329699-3E41F8CC-5346-4F4E-8173-45AF7A8E6AD1Q42980113-B1A5A04A-EAE3-4AD8-A3B2-D1CA1CC013C4Q42992916-251901F1-60F0-433B-A06E-CD0258C63FA5Q42996328-A4E8F044-673D-4C13-81B7-879DDF575078Q42998919-AD64547A-B89A-47D2-BEE3-5FDDC3768DB4Q43047358-FC31E7A4-EFBB-4923-A85E-FBE105EBC661Q46854672-446A4481-3600-42C0-BA8D-79AF83A88DD0Q47594606-55228034-749F-48B3-92B0-E38202A1D264Q51126531-C713CB44-DB44-4604-BD81-EA0F366FCA6FQ52661695-9AEFDB45-457A-4F18-983B-EA68937CBBD6Q55113960-2365C5C4-4AA1-4D92-806C-17EF29D41036
P2860
Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Insights into the epidemiology ...... and blood product recipients.
@ast
Insights into the epidemiology ...... and blood product recipients.
@en
Insights into the epidemiology ...... and blood product recipients.
@nl
type
label
Insights into the epidemiology ...... and blood product recipients.
@ast
Insights into the epidemiology ...... and blood product recipients.
@en
Insights into the epidemiology ...... and blood product recipients.
@nl
prefLabel
Insights into the epidemiology ...... and blood product recipients.
@ast
Insights into the epidemiology ...... and blood product recipients.
@en
Insights into the epidemiology ...... and blood product recipients.
@nl
P1476
Insights into the epidemiology ...... and blood product recipients.
@en
P2093
P304
P356
10.1016/S1246-7820(01)00125-2
P577
2001-06-01T00:00:00Z